Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis: Annals of the New York Academy of Sciences

Annals of the New York Academy of Sciences

Volumn 1193, Issue , 2010, Pages 139-145

  Todoerti, Monica ^a   Scirè, Carlo Alberto ^a   Boffini, Nicola ^a   Bugatti, Serena ^a   Montecucco, Carlomaurizio ^a   Caporali, Roberto ^a  

^a NONE

Author keywords

Clinical remission; Disease modifying drugs; Early disease activity control; Early rheumatoid arthritis; Longstanding clinical remission; Low dose glucocorticoids comedication

Indexed keywords

ALENDRONIC ACID; C REACTIVE PROTEIN; CALCIUM; CORTICOSTEROID; FOLIC ACID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VITAMIN D;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VISUAL ANALOG SCALE; VITAMIN SUPPLEMENTATION;

EID: 77951246294     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05367.x     Document Type: Conference Paper

References (21)

1. Bijlsma, J.W.J., M. Boers, K.G. Saag & D.E. Furst. 2003. Glucocorticoids in the treatment of early and late RA. Ann. Rheum. Dis. 62: 1033-1037.
2. Bijlsma, J.W.J., J.N. Hoes, A. van Everdingen, et al. 2006. Are glucocorticoidsDMARDs?Ann. N.Y.Acad. Sci. 1069: 268-274.
3. Bijlsma, J.W.J., A. van Everdingen, M. Huisman, et al. 2002. Glucocorticoids in rheumatoid arthritis. Ann. N.Y. Acad. Sci. 966: 82-90.
4. Boers, M., A.C. Verhoeven, H.M. Markusse, et al. 1997. Randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine in early rheumatoid arthritis. Lancet 350: 309-318.
5. Wassenberg, S., R. Rau, P. Steinfeld & H. Zeidler. 2005. Very low dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 52: 3371-3380.
6. Kirwan, J.R. 1995. The effect of corticosteroids on joint destruction in rheumatoid arthritis. N. Engl. J.Med. 333: 142-146.
7. Goekoop-Ruiterman, Y.P.M., J.K. de Vries-Bouwstra, C.F. Allaart, et al. 2005. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt Study): a randomized, controlled trial. Arthritis Rheum. 52: 3381-3390.
8. Van Everdingen, A.A., J.W. Jacobs, D.R. Siewertsz Van Reesema, & J.W. Bijlsma. 2002. Low dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties and side effects: a randomized, double-blind, placebocontrolled clinical trial. Ann. Intern. Med. 136: 1-12.
9. Svensson, B., A. Boonen, K. Albertsson, et al.; for the BARFOT Study Group. 2005. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patient with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. A two year randomised trial. Arthritis Rheum. 52: 3360-3370.
10. Hickling, P., R.K. Jacoby, J.R. Kirwan and the Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. 1998. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br. J. Rheumatol. 37: 930-936.
11. Saag, K.G., L.A. Criswell, K.M. Sems, et al. 1996. Low dose corticosteroids in rheumatoid arthritis: a metaanalysis of their moderate-term effectiveness. Arthritis Rheum. 39: 1818-1825.
12. Gotzsche, P.C. & H.K. Johansen. 1998. Meta-analysis of short-term low dose prednisolone versus placebo and non steroidal anti-inflammatory drugs in rheumatoid arthritis. BMJ 316: 811-818.
13. Aletaha, D., J. Funovitis, E.C. Keystone & J.S. Smolen. 2007. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. ArthritisRheum. 56: 3226-3235.
14. Aletaha, D., J. Funovitis, F.C. Breedveld, et al. 2009. Rheumatoid Arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthitis Rheum. 60: 1242-1249.
15. Arnett, F.C., S.M. Edworthy, D.A. Bloch, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
16. Van Der Heijde, D.M., M. van't Hof, P.L. van Riel & L.B. van de Putte. 1993. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J. Rhematol. 20: 579-581.
17. Van Gestel, A.M., M.L. Prevoo, M.A. van' t Hof, et al. 1996. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum. 39: 34-40.
18. Fries, J.F., P. Spitz & R.G. Kraines. 1980.Measurement of patient outcome in arthritis. Arthritis Rheum. 23: 137-145.
19. Ritchie,D.M., J.A. Boyle, J.M.McInnes, et al. 1968. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J. Med. 37: 393-406.
20. Prevoo, M.L., A.M. van Gestel, M.A. van't Hof, et al. 1996. Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br. J. Rheumatol. 35: 1101-1105.
21. Hafstrom, I., K. Albertsson, A. Boonen, et al. and the BARFOT Study Group. 2009. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann. Rheum. Dis. 68: 508-513.